u/oquido · 405d ago1 prior · awaiting results
Long ALGS
$ALGS, over 5000% potential with Best-in-class HBV & MASH candidates with strong data. The most complete independent report available for this company - Long read
Aligos Therapeutics has best-in-class HBV and MASH candidates with superior clinical data compared to current standards of care. With strong management (CEO formerly built companies acquired for billions), $122.9M cash runway, and leading pipeline assets (ALG-000184 as a capsid assembly modulator and a leading MASH candidate), the company has potential for significant appreciation from current $9.53 stock price.
At post $10.25live price unavailable
1d+4.9%
3d-4.5%
1w-4.4%
1m-7.4%
3m+4.9%
6m-33.6%
1y-45.8%